He has held senior commercial positions at Neomend, Incisive Surgical, and Vascular Solutions and serves on the boards of EndoShunt and VenoStent. Nagel succeeds Neil Ray, MD, the founder of Raydiant, ...

With more than 35 years of experience leading high-growth, innovative healthcare companies, Nagel joins Raydiant from Vomaris Innovations, a bioelectric wound care company, where he served as CEO and ...

TEL AVIV, Israel and MIAMI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today ...

HOUSTON--(BUSINESS WIRE)--#CART--Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), a clinical-stage, fully-integrated biotherapeutics company using its proprietary DIAMOND ® ...

Canary Medical Chief Medical Officer Dr. Patrick Verta [Image courtesy of Canary Medical] Canary Medical (Vancouver, British Columbia and Carlsbad, California) has appointed Dr. Patrick Verta as its ...

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update Eligible ...

Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update The ...

On Jul 4, we issued an updated research report on Murray Hill, NJ-based CR Bard Inc. (NYSE:BCR) – a global leader in the design, manufacture, packaging, distribution, and marketing of medical care ...

SINGAPORE, April 2, 2015 (Antara/PRNewswire) -- Johnson & Johnson Innovation - JJDC, Inc. (JJDC) today announced a USD $15 million commitment to Vivo Capital Fund VIII ("Vivo VIII"). Vivo Capital is ...

Vivo Capital has closed an oversubscribed eighth fund at $750 million to invest in later-stage pharma and medical device companies in the U.S. and revenue-stage companies in greater China. That's ...